FCX vs FOLD · P/E 38, rev $25.45B vs rev $528.3M
Freeport-McMoran Copper & Gold Inc (FCX) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the FCX and FOLD stock pages for the full models.
Not investment advice.